✦ LIBER ✦

Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients

✍ Scribed by Antongiulio Faggiano; Lidice Brandao Tavares; Libuse Tauchmanova; Francesco Milone; Gelsomina Mansueto; Valeria Ramundo; Maria Laura Del Basso De Caro; Gaetano Lombardi; Gaetano De Rosa; Annamaria Colao

Book ID: 108704177
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 791 KB
Volume: 69
Category: Article
ISSN: 0300-0664
DOI: 10.1111/j.1365-2265.2008.03301.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of multiple endocrine neoplas

Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours

✍ P. Langer; A. Wild; A. Hall; I. Celik; M. Rothmund; D. K. Bartsch 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

Octreotide improves biochemical, radiolo

Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with multiple endocrine neoplasia type 1 (MEN-1) : Implications for an integrated model of MEN-1 tumorigenesis

✍ John R. Burgess; Tim M. Greenaway; Venkateswaran Parameswaran; Joseph J. Shepher 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Multiple endocrine neoplasia type 1 (MEN-1) is an autosomal dominant tumor syndrome associated with parathyroid, gastroenteropancreatic (GEP), and pituitary neoplasia. Gastrinoma and GEP malignancy are common life-threatening endocrine complications of MEN-1. An effective management strategy for the